PNC Financial (PNC) to Post Q2 Earnings: Here's What to Expect
https://www.zacks.com/stock/news/2299468/pnc-financial-pnc-to-post-q2-earnings-here-s-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2299468
Jul 10, 2024 - PNC Financial's (PNC) second-quarter 2024 results are likely to be driven by an improved lending scenario and an increase in fee income, offset by rising expenses and higher provisions.
0
EWQ: Not Prudent To Bet On French Equities Post Election Results
https://seekingalpha.com/article/4703189-ewq-not-prudent-bet-french-equities-election-results?source=feed_tag_editors_picks
Jul 09, 2024 - iShares MSCI France ETF has had a choppy 2024 with only low single-digit returns. Learn why EWQ is currently undergoing a massive spike in volatility.
0
NFTY: The Large-Cap Play On India's Post-Election Phase
https://seekingalpha.com/article/4702530-nfty-etf-large-cap-play-on-india-post-election-phase?source=feed_tag_etf_portfolio_strategy
Jul 05, 2024 - Equal-weighted NFTY is well-placed to outperform the large caps. CLick here to see why the Fund is a Buy.
0
Kura Sushi (KRUS) to Post Q3 Earnings: What's in Store?
https://www.zacks.com/stock/news/2296762/kura-sushi-krus-to-post-q3-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2296762
Jul 03, 2024 - Kura Sushi's (KRUS) third-quarter fiscal 2024 performance is likely to reflect softness in the California market.
0
Cartesian posts mid-stage win for lead asset; Oppenheimer downgrades (update)
https://seekingalpha.com/news/4121525-cartesian-stock-gains-trial-win-lead-drug?source=feed_sector_healthcare
Jul 02, 2024 - Cartesian Therapeutics (RNAC) stock fell as Oppenheimer downgraded it even after a mid-stage trial win for its lead asset Descartes-08. Read more here.
0
Micron Technology, Inc. (MU) Post Earnings Q3 2024 Earnings Call Transcript
https://seekingalpha.com/article/4701990-micron-technology-inc-mu-post-earnings-q3-2024-earnings-call-transcript?source=feed_sector_transcripts
Jul 02, 2024 - Micron Technology, Inc. (NASDAQ:NASDAQ:MU) Post Earnings Q3 2024 Earnings Conference Call June 26, 2024 5:00 PM ETCompany ParticipantsSatya Kumar - IRManish...
0
Tandem Diabetes (TNDM) Posts Positive Data for Tandem Mobi
https://www.zacks.com/stock/news/2295786/tandem-diabetes-tndm-posts-positive-data-for-tandem-mobi?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2295786
Jul 01, 2024 - Tandem Diabetes (TNDM) unveils survey results of the new Tandem Mobi insulin delivery system, underscoring its potential to significantly enhance the quality of life for people with diabetes
0
Is Rivian (RIVN) a Buy Post VWAGY Deal & Investor Day Insights?
https://www.zacks.com/stock/news/2295807/is-rivian-rivn-a-buy-post-vwagy-deal-investor-day-insights?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2295807
Jul 01, 2024 - While the Volkswagen deal and cost-cutting plans are likely to drive Rivian's (RIVN) long-term growth, potential investors should wait for a better entry point, given near-term challenges.
0
Here's Why Post Holdings (POST) is a Strong Momentum Stock
https://www.zacks.com/stock/news/2295023/here-s-why-post-holdings-post-is-a-strong-momentum-stock?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2295023
Jun 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
CULP Posts Narrower-Than-Expected Q4 Loss, Lags Sales Estimates
https://www.zacks.com/stock/news/2294981/culp-posts-narrower-than-expected-q4-loss-lags-sales-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2294981
Jun 28, 2024 - CULP's fourth-quarter fiscal 2024 results reflect ongoing macroeconomic headwinds impacting the sales trend of the company across its two reportable businesses. Yet, operational excellence and restructuring initiatives bode well.
0